In contrast, they are very rare in MDS/MPN-RS-T (<3%), which is characterized by the presence of recurrent JAK2 mutations (35%) that are associated with thrombocytosis and that constitutively activate the JAK/STAT signaling pathway [74]. Here, JAK2 is linked to myeloproliferative neoplasm.